sun pharma 
Dealstreet

Universal Legal acts for Aksigen Hospital Care on the sale of anti-inflammatory brands to Sun Pharma

The deal amount remains undisclosed.

Bar & Bench

Aksigen Hospital Care, a research driven pharmaceutical company sold three of its DGCI approved anti-inflammatory brands to drug major Sun Pharmaceutical Industries for an undisclosed amount.

Universal Legal represented Aksigen Hospital Care in this transaction.

The transaction team consisted of Rashi Kapoor Mehta (Partner) and Neelkamal Chaudhary (Associate Partner).

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Delhi High Court restores ban on 2 FDCs for Type II Diabetes; says govt can ban drugs without proving harm

NLU Delhi wins NLIU-NHRC Moot Court Competition 2026

Jallikattu a State event; private individuals cannot organise it: Madras High Court

Souvik Roy and Kanishka Bajpai launch Mumbai-based Corporate firm Mantrika Legal

TT&A, Trilegal act on Lohia Aerospace Systems securing funds from Singularity AMC

SCROLL FOR NEXT